Overview
Dephy designs and sells wearable robotics that enhance human performance. Its products include exoskeletons, actuators, electronics, and software that together provide mobility augmentation for demanding tasks; the ExoBoot ankle exoskeleton uses sensors, human behavior models, and machine learning to decide when to assist and adapts to gait and fatigue. The company markets directly to military, academic, medical, business, and consumer sectors and collaborates with over 20 global research partners to move exoskeletons from lab to real-world use. Its goal is practical, safe, and effective human augmentation that improves mobility and task performance across diverse settings.
Work here?Claim your company
Simplify's take
What believers are saying
- Dephy expanded Sidekick on August 6, 2026, covering women’s 4 through men’s 16.
- The August 27, 2026 starter pack page shows shipping within 15 business days.
- Nike named Dephy a robotics partner for Project Amplify, validating its ankle-actuation leadership.
What critics are saying
- Sidekick costs $4,500, excluding many consumers and slowing mass-market adoption in 2027.
- If Nike Project Amplify or a larger rival ships first, Dephy loses category ownership.
- The company’s wellness positioning avoids medical reimbursement, limiting enterprise and clinical demand.
What makes Dephy unique
- Sidekick is the only ankle-powered consumer wearable shipping in the U.S. today.
- Dephy’s MIT biomechatronics lineage and 40 hardware iterations create deep gait-specific know-how.
- TÜV ISO 13482 certification and 20-stride learning give the product credibility and usability.
Help us improve and share your feedback! Did you find this helpful?